Mass General researchers say those who have a genetic disposition for storing fat deposits primarily at their waistline are at a higher risk of developing diabetes and coronary heart disease.
The Mass General Diabetes Unit is working toward a cure for the disease while making new and effective strides in prevention and treatment.
The FDA approves the second phase of Dr. Denise Faustman’s clinical testing of a type 1 diabetes vaccine, an exciting next step in her pursuit of a therapy to reverse the disease.
Mass General’s Diabetes Prevention Program made a big difference for one brother facing the very dangerous disease.
A Mass General expert offers those with prediabetes and diabetes some strategies to help delay and possibly prevent further advancement of the disease.
Mass General researcher and donor Joel Habener, MD, advances diabetes research and the careers of promising young investigators.
A team of scientists and engineers, led at the Massachusetts General Hospital Diabetes Center by Steven Russell, MD, PhD, have developed and are testing a first-of-its-kind automated device with the potential to revolutionize diabetes treatment. This medical breakthrough is called the bionic pancreas – and it’s closer than ever to making a real world impact on patients.
Endocrinologist Steven Russell, MD, PhD, of the Mass General Diabetes Center, and Edward Damiano, PhD, associate professor of biomedical engineering at Boston University, spent part of their summer at Camp Joslin, a summer camp for children with diabetes in western […]
The bionic pancreas is a prototype device designed to reduce the constant burden of monitoring and adjusting blood sugar levels for the millions of people with diabetes.
Genetics can help predict the risk for type 2 diabetes, but MGH researcher Jose C. Florez, MD, PhD, says exercise and diet can still prevent the disease.